NIP
IDXX icon

Nicholas Investment Partners’s Idexx Laboratories IDXX Stock Holding History

Nicholas Investment Partners’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-703
Closed -$276K – 181
2020
Q3 		$276K Buy
+703
New +$260K 0.03% 166
2017
Q3 		– Sell
-15,104
Closed -$2.44M – 262
2017
Q2 		$2.44M Buy
+15,104
New +$2.45M 0.17% 193

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return

Nicholas Investment Partners's IDXX Position: Q4 2020 in Review

Nicholas Investment Partners sold out of Idexx Laboratories (IDXX) in Q4 2020, closing a stake of 703 shares — an estimated $276K sold.

Nicholas Investment Partners first reported a position in IDXX in Q2 2017 and held it in 2 quarters. The position peaked at $2.44M in Q2 2017. 971 funds tracked by Wall St. Rank hold IDXX as of Q4 2020.

  • Nicholas Investment Partners reported no remaining Idexx Laboratories position as of Q4 2020 after selling out during the quarter.
  • Nicholas Investment Partners sold 703 Idexx Laboratories shares in Q4 2020, an estimated $276K.
  • Nicholas Investment Partners first reported a position in Idexx Laboratories in Q2 2017 and held it in 2 quarters.
  • Nicholas Investment Partners's Idexx Laboratories position peaked at $2.44M in Q2 2017.
  • 971 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2020.

Based on Nicholas Investment Partners's 13F filing for Q4 2020, filed 11 Feb 2021.